Vivasure Medical has announced the European launch of the PerQseal closure device for large-bore transcatheter procedures, including transcatheter aortic valve implantation (TAVI), thoracic endovascular aneurysm repair (TEVAR), and endovascular abdominal aneurysm repair (EVAR)—all of which require large bore femoral artery access.
A press release reports that PerQseal is the first sutureless, fully absorbable synthetic implant for large bore arterial punctures, adding that the PerQseal technology consists of an intravascular patch that seals the vessel from the inside, returning the artery to its natural state.
Horst Sievert (CardioVascular Center, Frankfurt, Germany) says: “Closing the artery has been a concern since we started using transcatheter techniques for valve implantation. The device is a very innovative solution for closing large holes, and we are enthusiastic to make it part of our armamentarium.”
Gerard Brett, co-founder and CEO of Vivasure Medical, states: “We are excited that the PerQseal device is now widely available to European physicians, providing a safe and simple option for the closure of large puncture holes that leaves behind no sutures, metal implants, or collagen. This commercial launch is a key milestone for Vivasure as we journey to enable better patient outcomes in fully percutaneous large bore endovascular procedures.”
